Zoom Logo

RADx Tech for Maternal Health Info Session - Shared screen with speaker view
Michele Liston
59:47
Hi everyone! Please use the chat functionality to submit your questions! We'll get to as many as time allows following the prepared remarks!
Theadora James
01:00:51
Hi Michele. Will the recording and presentation be sent to the attendees?
Christine Rohan
01:03:05
Is a company better off submitting an application earlier and less complete vs. later but later than more complete, within the application submission window?
Marie-Antoinette Tichler
01:04:25
Will Proof of Concepts be allowed to enter the challenge?
Isabel Fulcher (she/her)
01:12:43
Will the submissions be scored based on the *novelty* of the technology itself OR the anticipated impact?
Brad Schneider
01:13:00
Would conditions that are a risk during and after pregnancy, e.g., preeclampsia, in scope?
Christine Rohan
01:17:26
Just to be clear, will the uploaded clinical and usability data will be considered confidential?
Brad Schneider
01:22:10
Is there a maximum limit to the allowable cost of the platform at the POC (e.g., the cost of the device required to conduct the test)? Would home sample collection and testing at a central lab be within scope?
Michele Liston
01:24:19
We will share this slide deck with all of you after the call!
Ali Roghani
01:28:26
Does the proof-of-concept data have to be published in a peer reviewed manuscript or can it be recent data that has been collected in a clinical trial?
Himanshu Sant
01:29:00
Is technology focused on neonatal care acceptable?
Dawn-ProThera
01:33:34
There is no restriction on use of prize as long as grant funding is not used for the submission. Does this apply to only current grants or does it include technology developed with previous grants that are now closed.
Isabel Fulcher (she/her)
01:34:44
Thank you!
Christine Rohan
01:35:15
Thank you. You answered both of my questions.
Shu
01:35:21
What is the IP position requirement for the technologies submitted? Thank you
Marlena Fejzo
01:36:21
Is adapting an app for android that we made already for iphone in the scope of this challenge?
Nick Picca
01:36:57
How is team composition, track-record, facilities, and likelyhood for success taken into account?
Kelsey Mayo
01:37:00
In the application, if the entity applying is a early-stage start-up, should we answer questions (i.e. “Are your facilities registered with the FDA”) based on manufacturing partners we plan to contract?
Bridgie A. Ford, Ph.D.
01:37:23
So the sole focus is on the Maternal Side and not the Fetus side?
Brad Schneider
01:40:58
Just to clarify, if the technology requires home collection of a sample and then is shipped and tested at a central laboratory, is this within scope?
Brad Schneider
01:42:42
thanks
Richard A Cordova
01:45:05
Can you elaborate on what you're looking for in the proof-of-concept data? Can this include previous research data demonstrating the impact of your general approach, but not using your specific solution?
Christina Marie Davis
01:46:37
Will submissions made prior to mid-October when you expect to begin the reviewing process be queued up and reviewed on a first come first serve basis?
Isabel Fulcher (she/her)
01:47:44
Thank you - super informative!
Christine Rohan
01:47:46
This was very helpful. Thank you!
Kelsey Mayo
01:47:47
Thank you so much! This was very informative.
Himanshu Sant
01:47:50
Thanks
Christina Marie Davis
01:47:51
Thank you!
Roni Cantor-Balan, Ciconia Medical
01:47:57
Thank you very much!
Sarah Goodday
01:48:00
Thanks!!